4.8 Article

Rapid detection of intact SARS-CoV-2 using designer DNA Nets and a pocket-size smartphone-linked fluorimeter

Journal

BIOSENSORS & BIOELECTRONICS
Volume 229, Issue -, Pages -

Publisher

ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2023.115228

Keywords

Biosensor; Portable fluorometer; Point-of-care test; Designer DNA Nanostructure; Smartphone; COVID-19 testing

Ask authors/readers for more resources

We report the development of a compact and affordable fluorimeter called a Virus Pod (V-Pod) for sensitive self-testing of SARS-CoV-2 viral load in saliva. The device utilizes Designer DNA Nanostructures (DDN) that specifically interact with the virus to generate fluorescence signals. The V-Pod instrument performs sample testing and data transmission, offering a rapid and quantitative output compatible with frequent self-testing.
Rapid, sensitive, and inexpensive point-of-care diagnosis is vital to controlling highly infectious diseases, including COVID-19. Here, we report the design and characterization of a compact fluorimeter called a Virus Pod (V-Pod) that enables sensitive self-testing of SARS-CoV-2 viral load in saliva. The rechargeable battery-operated device reads the fluorescence generated by Designer DNA Nanostructures (DDN) when they specifically interact with intact SARS-CoV-2 virions. DDNs are net-shaped self-assembling nucleic acid constructs that provide an array of highly specific aptamer-fluorescent quencher duplexes located at precise positions that match the pattern of spike proteins. The room-temperature assay is performed by mixing the test sample with DNA Net sensor in a conventional PCR tube and placing the tube into the V-Pod. Fluorescent signals are generated when multivalent aptamer-spike binding releases fluorescent quenchers, resulting in rapid (5-min) generation of dose-dependent output. The V-Pod instrument performs laser excitation, fluorescence intensity quantitation, and secure transmission of data to an App via Bluetooth (TM). We show that the V-Pod and DNA Net assay achieves clinically relevant detection limits of 3.92 x 10(3) viral-genome-copies/mL for pseudo-typed wild-type SARS-CoV-2 and 1.84 x 10(4), 9.69 x 10(4), 6.99 x 10(4) viral-genome-copies/mL for pathogenic Delta, Omicron, and D614G variants, representing sensitivity similar to laboratory-based PCR. The pocket-sized instrument (similar to$294), inexpensive reagent-cost/test ($1.26), single-step, rapid sample-to-answer, and quantitative output represent a capability that is compatible with the needs of frequent self-testing in a consumer-friendly format that can link with medical service systems such as healthcare providers, contact tracing, and infectious disease reporting.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available